Indraprastha Medical Corporation Ltd vs Sunil Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 305.15 as of 30 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Sunil Healthcare Ltd changed from 11.4 on March 2022 to 15.9 on March 2026 . This represents a CAGR of 6.88% over 5 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Sunil Healthcare Ltd changed from ₹ 23.43 crore on March 2021 to ₹ 63.55 crore on March 2026 . This represents a CAGR of 18.09% over 6 years The revenue of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sunil Healthcare Ltd for the Jun '26 is ₹ 19.21 crore as compare to the Mar '26 revenue of ₹ 20.13 crore. This represent the decline of -4.57% The ebitda of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sunil Healthcare Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 2.23 crore. This represent the growth of 41.26% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sunil Healthcare Ltd changed from ₹ -0.69 crore to ₹ 0.46 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Sunil Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About Sunil Healthcare Ltd

Sunil Healthcare Limited (Formerly known Sunil Synchem Ltd) was incorporated in 1973.
The Company introduced plant at Alwar; Rajasthan for manufacture of Empty Hard Gelatin Capsule Shells and HPMC Capsules Shell.
With continuous efforts and improvements in policy & adherence to top-notch quality monitoring measures, the Company became the second-largest manufacturer of Empty Hard Gelatin Capsules (EHGC) in India. The Company is WHO-GMP certified Company and has also been recognized as 'Star Export House' by GoI. The Company commenced its manufacturing operation in 1976 with installed capacity of 200 million Hard Gelatin Capsule Shell.
With gradual expansion, it reached to the installed capacity of 10930 million capsules p.a.
The product of the Company Hard Gelatin Capsule Shell is used by Pharmaceutical and Food supplement Companies as a container for administering medicines and food supplements.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Sunil Healthcare Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,797 Cr while Market cap of Sunil Healthcare Ltd is 69 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd?

As of November 1, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹305.15. On the other hand, Sunil Healthcare Ltd stock price is INR ₹67.8.

How do dividend payouts of Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Sunil Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.